2Mo XD, Xu LP, Liu DH, et al. Patients receiving HLA-haploidentical/ partially matched related allo-HSCT can achieve desirable health- related QoL that is comparable to that of patients receiving HLA- identical sibling allo-HSCT. Bone Marrow Transplant, 2012, 47: 1201-1205.
3Grigg A, Bardy P, Byron K, et al. Fludarabine-based non-myelo- ablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma. Bone Marrow Trans- plant, 1999, 23: 107-110.
4Liu D, Huang X, Liu K, et al. Haploidentieal hematopoietie stem cell transplantation without in vitro T cell depletion for treatment of hematological maligriancies in children. Biol Blood Marrow Trans- plant, 2008 , 14: 469-477.
5Aplene R, Alonzo TA, Gerbing RB, et al. Ethnicity and survival in childhood acute myeloidleukemia: a report fi'om the Children's Oncology Group. Blood, 2006, 108: 74-80.
6Leung W, Campana D, Yang J, et al. High success rate of hemato- poietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood, 2011, 115: 223-230.
7Wang Y, Liu Dh, Xu LP, et al. Superior graft-versus-leukemia effect associated with transplantation of haploidentieal compared with HLA- identical sibling donor grafts for high-risk acute leukemia: an historic comparison. Biol Blood Marrow Transplant, 2011, 17 : 821-830.
8Lu DP,Dong L,Wu T,et al.Conditioning including antithy-mocyte globulin followed by un-manipulated HLA-mismathed/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation[J].Blood,2006,107(8):3065-3073.
9Ferrara J, Antin J. Thomas Hematopoietic cell transplantation [M]. 4th ed. Malden: Wiley-Blackwell Publishing l,td, 2009: 353-368.
10Harris A C, Ferrara J I., Levine J E. Advances in predicting acuteGVHD [J]. BrJ Haematol, 2013, 160 (3): 288-302.
